Literature DB >> 9230375

Rapid characterization schemes for surveillance isolates of vancomycin-resistant enterococci.

D F Sahm1, L Free, C Smith, M Eveland, L M Mundy.   

Abstract

Surveillance cultures for vancomycin-resistant enterococci (VRE) and subsequent characterization of the isolates can be extremely burdensome and difficult. Therefore, efficient and reliable schemes for the characterization of surveillance isolates are needed. In this study, a commercial agar (bile esculin azide agar with 6 microg of vancomycin per ml [BEAA]; Remel, Lenexa, Kans.) was used in the initial screening step to establish relatively rapid (i.e., in < or = 24 h from the time of isolation) phenotype-based and PCR-based schemes for the detection and characterization of VRE. The phenotype-based scheme included Gram staining of growth on BEAA and subculture of cocci on sheep blood agar plates for vancomycin disk diffusion and pyrazinamidase (PYR) testing. For the PCR scheme, inocula for van gene detection were taken directly from the BEAA plates. The phenotypic approach was applied to 378 surveillance cultures that yielded growth on BEAA. Gram staining quickly eliminated gram-positive bacilli from further testing, and a negative PYR test classified 25 additional isolates as probable pediococci. A positive PYR test reliably identified 121 single-patient VRE isolates that included 83 Enterococcus faecium, 33 E. gallinarum, and 5 E. casseliflavus strains. The vancomycin inhibition zone size clearly distinguished VanA and VanB strains from VanC strains within 24 h of BEAA isolation. All VanA and VanB strains failed to produce zones of >6 mm, while only one VanC strain produced a zone of < 15 mm. Challenging this phenotypic scheme with 47 stock VRE isolates produced similar findings. In direct PCR analyses, false-negative vanA and vanB results occurred with 12% of the specimens. Many of the false-negative reactions also failed to produce an internal control product, which underscores the need for including control primers when a PCR scheme is used. In summary, the phenotype- and the PCR-based schemes provide efficient methods for characterizing VRE within 24 h of isolation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230375      PMCID: PMC229896          DOI: 10.1128/jcm.35.8.2026-2030.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci.

Authors:  D Landman; J M Quale; E Oydna; B Willey; V Ditore; M Zaman; K Patel; G Saurina; W Huang
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 2.  Genetics and mechanisms of glycopeptide resistance in enterococci.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

3.  Rapid detection of vancomycin-resistant enterococci.

Authors:  S C Edberg; C J Hardalo; C Kontnick; S Campbell
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

4.  Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus.

Authors:  S Dutka-Malen; B Blaimont; G Wauters; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

5.  Selective isolation of vancomycin-resistant enterococci.

Authors:  K G van Horn; C A Gedris; K M Rodney
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

6.  Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp.

Authors:  J E Schulz; D F Sahm
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients.

Authors:  M Green; K Barbadora; M Michaels
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

8.  Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients.

Authors:  B Gordts; H Van Landuyt; M Ieven; P Vandamme; H Goossens
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

9.  Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center.

Authors:  J G Morris; D K Shay; J N Hebden; R J McCarter; B E Perdue; W Jarvis; J A Johnson; T C Dowling; L B Polish; R S Schwalbe
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

10.  PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid.

Authors:  K Greisen; M Loeffelholz; A Purohit; D Leong
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

View more
  14 in total

1.  Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci.

Authors:  R Kariyama; R Mitsuhata; J W Chow; D B Clewell; H Kumon
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin.

Authors:  L R Baden; I A Critchley; D F Sahm; W So; M Gedde; S Porter; R C Moellering; G Eliopoulos
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 3.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Use of colony morphology to distinguish different enterococcal strains and species in mixed culture from clinical specimens.

Authors:  Shabnam Qamer; Jonathan A T Sandoe; Kevin G Kerr
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci.

Authors:  Y S Chen; S A Marshall; P L Winokur; S L Coffman; W W Wilke; P R Murray; C A Spiegel; M A Pfaller; G V Doern; R N Jones
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Comparison of simple and rapid methods for identifying enterococci intrinsically resistant to vancomycin.

Authors:  K L Hanson; C P Cartwright
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens.

Authors:  Paul D Stamper; Mian Cai; Clara Lema; Kim Eskey; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2007-08-17       Impact factor: 5.948

8.  Characterization of glycopeptide-resistant enterococci from a Swiss hospital.

Authors:  N Liassine; R Frei; I Jan; R Auckenthaler
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

9.  Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay.

Authors:  Silvano Palladino; Ian D Kay; James P Flexman; Ingrid Boehm; Anna Maria G Costa; Erica J Lambert; Keryn J Christiansen
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin.

Authors:  David R Snydman; Laura A McDermott; Cheleste M Thorpe; Justin Chang; Jenna Wick; Seth T Walk; Richard J Vickers
Journal:  J Antimicrob Chemother       Date:  2018-08-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.